Form 8-K - Current report:
SEC Accession No. 0001641172-25-015520
Filing Date
2025-06-18
Accepted
2025-06-18 08:43:39
Documents
32
Period of Report
2025-06-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 38890
2 EX-99.1 ex99-1.htm EX-99.1 15890
3 GRAPHIC ex99-1_001.jpg GRAPHIC 271873
4 GRAPHIC ex99-1_002.jpg GRAPHIC 427478
5 GRAPHIC ex99-1_003.jpg GRAPHIC 135341
6 GRAPHIC ex99-1_004.jpg GRAPHIC 51209
7 GRAPHIC ex99-1_005.jpg GRAPHIC 256371
8 GRAPHIC ex99-1_006.jpg GRAPHIC 42386
9 GRAPHIC ex99-1_007.jpg GRAPHIC 63291
10 GRAPHIC ex99-1_008.jpg GRAPHIC 84089
11 GRAPHIC ex99-1_009.jpg GRAPHIC 197970
12 GRAPHIC ex99-1_010.jpg GRAPHIC 154536
13 GRAPHIC ex99-1_011.jpg GRAPHIC 190439
14 GRAPHIC ex99-1_012.jpg GRAPHIC 70925
15 GRAPHIC ex99-1_013.jpg GRAPHIC 46618
16 GRAPHIC ex99-1_014.jpg GRAPHIC 237482
17 GRAPHIC ex99-1_015.jpg GRAPHIC 74274
18 GRAPHIC ex99-1_016.jpg GRAPHIC 57895
19 GRAPHIC ex99-1_017.jpg GRAPHIC 220974
20 GRAPHIC ex99-1_018.jpg GRAPHIC 279678
21 GRAPHIC ex99-1_019.jpg GRAPHIC 201848
  Complete submission text file 0001641172-25-015520.txt   4438862

Data Files

Seq Description Document Type Size
22 XBRL SCHEMA FILE pvct-20250618.xsd EX-101.SCH 3026
23 XBRL LABEL FILE pvct-20250618_lab.xml EX-101.LAB 34239
24 XBRL PRESENTATION FILE pvct-20250618_pre.xml EX-101.PRE 22366
34 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3363
Mailing Address 800 S. GAY STREET SUITE 1610 KNOXVILLE TN 37929
Business Address 800 S. GAY STREET SUITE 1610 KNOXVILLE TN 37929 (866) 594-5999
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

EIN.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36457 | Film No.: 251055257
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)